Abstract:307 Background: Since 2005, the United States Preventive Services Task Force (USPSTF) recommends that primary care (PC) clinicians identify and refer adults with a high-risk cancer family history to cancer genetic services (CGS), yet hereditary cancer risk assessment (HCRA) continues to be underutilized in PC. A population-based approach to HCRA in PC settings can expand access to cancer prevention and early detection to vulnerable populations and reduce disparities in cancer outcomes. The Chicago Cancer Screening and Testing Access Coalition (CCSTAC) is developing strategies to integrate HCRA in PC settings. We conducted an environmental scan to assess current capacity to deliver 1) HRCA in Federally Qualified Health Centers (FQHCs) and 2) follow-up CGS for high risk patients. Methods: In 2023, we administered two surveys to assess HCRA practices in Metro Chicago. We invited 22 FQHCs to complete a 21-item survey of current practices, readiness to implement, and barriers to HCRA. We also invited 21 CGS sites to complete a 25-item survey to understand staffing, utilization, referral patterns, and barriers to access. Surveys were administered electronically via Qualtrics. We conducted a descriptive analysis of survey data. Results: Twenty FQHCs (91%) completed the survey on HCRA in PC; 85% reported familiarity with USPSTF guidelines for HCRA. The majority (75%) reported no plans to implement HCRA. Clinic workflow, paucity of follow-up resources, cost, lack of provider knowledge, and absence of HCRA as a mandatory performance measure were cited as the most significant barriers to implementation. Genetic counselors (GCs) from 19 CGS hospital-based sites (90%) completed the survey on availability of genetic services. CGS were most often located in a cancer center (47%); no CGS were located in PC. Most referrals originated from oncology, surgery, or gastroenterology, with the lowest rate of referrals from community-based PC. Nearly half of CGS clinics (47%) reported capacity for at least a small increase in patient volume. Wait-time at the majority of CGS clinics was less than a month. GCs cited patient logistics (e.g. transportation, time off work), lack of referral information from providers, and systemic racism as significant barriers in patient access to CGS. Conclusions: After almost 20 years of evidence-based guidelines, use of HCRA is still very limited in the community-based PC setting. Our findings point to a need to bridge the gap between hospital-based CGS and FQHCs to ensure patients in vulnerable communities have access to guideline-concordant cancer prevention and screening strategies. Based on these findings, CCSTAC is designing strategies to integrate HCRA in primary care at FQHCs focused on provider education, well-designed clinic workflows, connections with existing CGS, and advocacy to align UDS and HEDIS measures with USPSTF guidelines.

Propagation of sepsis in vascular grafts.

Exploring genetic counselors' experiences with non‐paternity in clinical settings

Status of abortion curriculum in genetic counseling: Survey of graduate programs and recent graduates in the United States

RNA Virus Population Diversity, an Optimum for Maximal Fitness and Virulence*

Navigating the Impact of the 21st Century Cures Act Final Rule: A National Survey of U.S. Genetic Counselors

Navigating the Impact of the 21st Century Cures Act Final Rule: A National Cross-Sectional Survey of U.S. Genetic Counselors

Further defining the roles and impact of genetic counselors in the biotechnology and pharmaceutical industry

Termination counseling among US perinatal genetic counselors in the setting of second trimester fetal anomalies

Exploring genetic counselors' interest and role in transitional care discussions for pediatric patients with neurodevelopmental conditions

Genetic counselors' and community clinicians' implementation and perceived barriers to informed consent during pre‐test counseling for hereditary cancer risk

Inconvenient sampling: Community‐engaged and restorative justice approaches to genetic counseling student research

Becoming agents for genomic change: genetic counsellors' views of patient care and implementation influences when genomics is mainstreamed

Use of gender‐inclusive language in genetic counseling to optimize patient care

A profile of genetic counseling and testing in Chinese patients with gynecologic oncology: a nationwide survey of Chinese gynecologists

Strength of the genetic counselor: patient relationship is associated with extent of increased empowerment in patients with arrhythmogenic cardiomyopathy

Use of Reproductive and Sexual Health Services Among Female Family Planning Clinic Clients Exposed to Partner Violence and Reproductive Coercion

Parent‐reported genetic counselor adherence to the NSGC practice resource for communicating a potential prenatal diagnosis: Impact on the Down syndrome diagnosis experience

Assessing capacity for hereditary cancer risk assessment in metro Chicago.

Towards equity & inclusion: a critical examination of genetic Counselling Education on Intersex Healthcare

Exploring perceptions of genetic counseling student‐run free clinics as an innovative service delivery model to increase access to genetic counseling services

Measuring quality and value in genetic counseling: The current landscape and future directions